Opt2mise 2

 

Only MiniMed insulin pump therapy is clinically proven to reduce A1C* better than MDI1


MiniMed insulin pump therapy chart

Efficacy



1.1%
A1C drop with MiniMed insulin pump therapy versus 0.4% in the group on multiple daily injections

0.7 % between groups difference in A1C in favor of MiniMed insulin pump therapy

Patients that achieved A1C <8%
2x
Almost twice as many patients achieve A1C < 8% with MiniMed insulin pump therapy

*Results achieved do not guarantee results in all prospective new patients; variability as between patients is possible.
1Reznik Y, Cohen O, Aronson R, et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomized open-label controlled trial. The Lancet. 2014. DOI 10.1016/S0140-6736(14)61037-0.